chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Expired product administered, Injection site induration, Injection site oedema, Injection site warmth
Clinical narrative: Case number PHHY2012US085746 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 461387) website on 02 Oct 2012. This report refers to a 12-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with expired MENVEO (batch number: M11051) and HAVRIX (batch number: AHAVB646AA) intramuscularly on to right arm and BOOSTRIX (batch number AC52B087CB) and GARDASIL (batch number: 1668AA) intramuscularly on to left arm and VARIVAX (batch number G016512) subcutaneously on to right arm on 03 Aug 2012. It was reported that she experienced 5x3 cm area of warmth, half cm area of induration and non tender mild edema in right posterior upper arm on 06 Aug 2012. It was reported that she would start treatment with BACTRIM. The final outcome of the event was reported as condition unchanged as of 08 Aug 2012.
Age: 16.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Vaccination site erythema, Vaccination site oedema, Vaccination site pain
Clinical narrative: Case number PHHY2012US085749 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 461471) web site on 02 Oct 2012. This report refers to a 16-year-old male patient. His medical history included obesity, Attention deficit/hyperactivity disorder (ADHD), Asperger's disorder, developmental and speech delay and current condition included allergic rhinitis. His vaccination history included VARIVAX (other manufacturer, batch number: not reported) on an unknown date and local reaction following it. It was reported that he had a sibling who had experienced local reaction following VARIVAX (other manufacturer and batch number: not reported). His concomitant medications were CONCERTA, SINGULAIR and loratadine. He was vaccinated with MENVEO (batch number: M10132) and HAVRIX (batch number: AHAVB586BA, other manufacturer) intramuscularly on to left arm on 30 Jul 2012. On 01 Aug 2012, he experienced tenderness, edema and erythema at vaccination site. He went to emergency room. The outcome of the event was reported as condition unchanged as of 09 Aug 2012. No further information was available.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Dizziness, Feeling cold, Pyrexia
Clinical narrative: Case number PHHY2012US085621 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 461601) on 02 Oct 2012. This case refers to a 17-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: not reported) on 08 Aug 2012. On 09 Aug 2012 he felt dizzy, cold and fever. He also had calicus on both hands. He took TYLENOL and went to emergency room to get checked out. The doctor stated that the patient had adverse reaction to meningitis immunization and gave him MOTRIN. He had recovered completely as of 10 Aug 2012. No other information was available.
Age: 11.0
Sex: M
Vaccine: IPV, MNQ
Symptoms: Injection site erythema, Injection site rash, Pyrexia, Rash erythematous
Clinical narrative: Case number PHHY2012US085624 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 461754) on 02 Oct 2012. This case refers to an 11-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M10123) intramuscularly into his left arm on 01 Aug 2012. On the same day he was also vaccinated with IPOL (other manufacturer, batch number: G1083) subcutaneously. On 01 Aug 2012 approximately at 8 pm the patient developed red bumps on left arm extending from shoulder to hand that look like mosquito bite. He also had one bump on right shoulder blade. He had fever of 104 degrees. Fever responded for OTC (over the counter) ibuprofen but it returned within six hours after taking ibuprofen. He had an emergency doctor visit due to these events. The final outcome was reported as not recovered as of 02 Aug 2012. No other information was available.
Age: 16.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Myosclerosis, Nausea, Pyrexia, Urticaria, Vomiting
Clinical narrative: Case number PHHY2012US085628 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 461804) on 02 Oct 2012. This case refers to a 16-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A11052) intramuscularly into his left arm on 02 Aug 2012. On the same day he was also vaccinated with GARDASIL (batch number: 0555AE) intramuscularly into his left arm. He experienced fever within eight hours after vaccination. On 03 Aug 2012 within 24 hours after vaccination he experienced nausea, vomiting, hives and local muscle induration. The final outcome was reported as condition unchanged as of 03 Aug 2012. No other information was available. Following an internal review of 15 Oct 2012 of the information received on 02 Oct 2012. Event fever was coded.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US098883 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461930) web site on 01 Nov 2012. This report refers to an 11-years-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with MENVEO (batch number: X10134A) intramuscularly in the right arm and also vaccinated with GARDASIL (other manufacturer, batch number: 1495AA) intramuscularly in the right arm on 07 Aug 2012. He was concomitant also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B074C) intramuscularly in the left arm on 07 Aug 2012. On 09 Aug 2012, he experienced red, swollen, painful and warm to touch in the right deltoid. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Acne, Rash, Skin ulcer
Clinical narrative: Case number PHHY2012US098893 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 461954) on 01 Nov 2012. This case refers to a 16-year-old female patient. She had no known drug allergy. She was vaccinated with MENVEO (batch number: M11064) into her left arm on 27 Jul 2012. On the same day, she was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B087BC) into her left arm. On 28 Jul 2012, she developed rash which started first in bikini area and spread to thighs. It looked like little pimples and they exploded, became sores after. She had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 08 Aug 2012.
Age: 14.0
Sex: F
Vaccine: MNQ, MNQ, TDAP, VARCEL
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Pruritus generalised
Clinical narrative: Case number PHHY2012US098895 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461975) web site on 01 Nov 2012. This report refers to a 14-years-old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: A11052) in the right arm on 07 Aug 2012,. On 08 Aug 2012, she experienced pain at injection site, itching whole body, injection site size of golf ball and warm at injection site. She was treated with BENADRYL, applied cold compress and advised to visit or call to the physician as soon as possible. The final outcome of the events was reported as condition unchanged at the time of reporting of 08 Aug 2012. The causality of the events was not reported.
Age: 14.0
Sex: F
Vaccine: MNQ, MNQ, TDAP, VARCEL
Symptoms: Dizziness, Fall, Skin abrasion
Clinical narrative: Case number PHHY2012US098895 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461975) web site on 01 Nov 2012. This report refers to a 14-years-old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: A11052) in the right arm on 07 Aug 2012,. On 08 Aug 2012, she experienced pain at injection site, itching whole body, injection site size of golf ball and warm at injection site. She was treated with BENADRYL, applied cold compress and advised to visit or call to the physician as soon as possible. The final outcome of the events was reported as condition unchanged at the time of reporting of 08 Aug 2012. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ, TDAP, VARCEL
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Pruritus generalised
Clinical narrative: Case number PHHY2012US099084, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461975) web site on 01 Nov 2012. This report refers to 11 year old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11064), intramuscular into the left arm, BOOSTRIX (batch number: AC52B081BA), intramuscular into the right arm and VARIVAX (batch number: 0669AA), subcutaneous into right arm on 28 Aug 2012. He received immunizations and walked outside with his father and younger brother to car.  Father realized that he forgot to turn his paperwork in to immunization clerical office and turned to go back into Health Department and at this time, the patient became light-headed and fell down. The patient had minor abrasion to left side of upper cheek - no bleeding noted. The patient's father stated that the patient did not lose consciousness. The patient went to the Immunization waiting room to sit down until lightheadedness subsided which took approximately 10 minutes. The patient left Health Department with his father and brother. The event outcome was recovered. Seriousness and causality assessment was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ, TDAP, VARCEL
Symptoms: Dizziness, Fall, Skin abrasion
Clinical narrative: Case number PHHY2012US099084, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 461975) web site on 01 Nov 2012. This report refers to 11 year old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M11064), intramuscular into the left arm, BOOSTRIX (batch number: AC52B081BA), intramuscular into the right arm and VARIVAX (batch number: 0669AA), subcutaneous into right arm on 28 Aug 2012. He received immunizations and walked outside with his father and younger brother to car.  Father realized that he forgot to turn his paperwork in to immunization clerical office and turned to go back into Health Department and at this time, the patient became light-headed and fell down. The patient had minor abrasion to left side of upper cheek - no bleeding noted. The patient's father stated that the patient did not lose consciousness. The patient went to the Immunization waiting room to sit down until lightheadedness subsided which took approximately 10 minutes. The patient left Health Department with his father and brother. The event outcome was recovered. Seriousness and causality assessment was not reported.
Age: 15.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Back pain, Neck pain, Pain
Clinical narrative: Case number PHHY2012US098896 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462026) website on 01 Nov 2012. This report refers to a 15-years-old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: M11071) in the left arm and also vaccinated with BOOSTRIX (other manufacture, batch number: AC52B065AA) in the right arm on 13 Aug 2012. On 14 Aug 2012, she experienced neck pain, back pain and side pain. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Urticaria
Clinical narrative: Case number PHHY2012US098900 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number 462136) on 01 Nov 2012. This case refers to a 11-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M10126A) intramuscularly into her left arm on 16 Jul 2012. On the same day she was also vaccinated with HAVRIX (other manufacturer, batch number: AHAVB513AA) intramuscularly into her left arm, GARDASIL (other manufacturer, batch number: 1778U) intramuscularly into her right arm. BOOSTRIX (other manufacturer, batch number: AC52B071BB) intramuscularly into her right arm and VARIVAX (other manufacturer, batch number: 0823AA) subcutaneously into her right arm. On 16 Jul 2012 the same day of vaccination she presented with 3 1/2 x 4 inch welt in left arm. Twenty four hours after vaccination she came with her mom to the health department. Her mom denied of fever, vomiting, diarrhea and hives. The patient was referred to emergency room (ER). ER physician recommended BENADRYL and cold compress. Next day morning she had recovered from the event completely. No other information was available.
Age: 18.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Eye haemorrhage
Clinical narrative: Case number PHHY2012US098907 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 462182) on 01 Nov 2012: This report refers to an 18-years-old female patient. She was vaccinated with MENVEO (batch number: M11041) intramuscularly into the left arm along with ADACEL (other manufacturer, batch number: 53941AA) intramuscularly in to the right arm on 14 Aug 2012. On 15 Aug 2012, she developed a 1/4 inch broken blood vessel in the outer right aspect of her eye that was noticed at around 3pm. The patient's mother stated the patient had no other symptoms and denied headache, fever or vision loss. She stated her only concern was that patient had the vaccines a day before. She was made aware to monitor the eye and contact clinic or emergency room in the event that patient developed headache, fever, or visual problems. The final outcome of the reaction was reported as not yet recovered as on 16 Aug 2012. No further information about causality and seriousness was provided.
Age: 12.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2012US098908 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462184) website on 01 Nov 2012. This report refers to a 12-years-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with MENVEO (batch number: A11047) intramuscularly in the left arm and also vaccinated with VARIVAX (other manufacture, batch number: 0830AA) intramuscularly in the left arm on 13 Aug 2012. On 14 Aug 2012, he experienced swelling, pain, itching at left deltoid for one day and 10x11 cm area of erythema. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Case number PHHY2012US098910 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462231) website on 01 Nov 2012. This report refers to an 18-years-old female patient. Her concomitant medication included LEVORA oral contraceptive. She came to receive meningitis vaccine and received only Men C, Y, W-135 liquid conjugate component of MENVEO vaccine (batch number: X10061), intramuscularly in the right arm without being reconstituted with Men A component on 11 Aug 2012. No adverse reaction reported following this administration error.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2012US098912 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 462260) on 01 Nov 2012. This case refers to a 11-year-old male patient. He was vaccinated with MENVEO (batch number: M11046) intramuscularly into his left arm 15 Aug 2012. On the same day he was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B088AA) intramuscularly into his left arm and GARDASIL (other manufacturer, batch number: H010123) intramuscularly into his right arm. On 16 Aug 2012 he developed swelling in left upper arm (16x14 cm) with redness and tenderness. He also had systemic fever. He was given treatment with ibuprofen, BENADRYL and ice. He had recovered completely on an unspecified date.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Mobility decreased, Pain in extremity, Rash
Clinical narrative: Case number PHHY2012US098919 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462401) web site on 01 Nov 2012. This report refers to a 19-years-old female patient. Her medical history and concomitant medication was not reported. She was vaccinated with MENVEO (batch number: A11073) in the left arm on 26 Jul 2012. On 27 Jul 2012, she developed large rash and pain injected arm. On 28 Jul 2012, she could barely mover her arm. Followed up with her on 30 Jul 2012 and she was doing better. She was self-treated with ibuprofen, ice and BENADRYL. The final outcome of the events was reported as completely recovered. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2012US098925 is an initial spontaneous report received from Vaccine Adverse Event Reporting System web site (VAERS reference number: 462606) on 01 Nov 2012. This case refers to a 11-year-old male patient. His preexisting condition included of anxiety disorder. He was vaccinated with MENVEO (batch number: A11064) into his left arm on 17 Aug 2012. On the same day he was also vaccinated with HAVRIX (batch number: AHAVB549CA into his left arm, ADACEL (other manufacturer, batch number: AC52B09413A) into his right arm and with VARIVAX (other manufacturer, batch number: H006531) into his right arm. On 18 Aug 2012, he developed swelling and redness at injection site. On 19 Aug 2012 his mom took him to urgent care and was given BENADRYL with prednisone. On 20 Aug 2012 he was feeling better. On an unspecified date he had recovered completely. No other information was available.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Headache, Influenza like illness, Injection site erythema, Injection site macule
Clinical narrative: Case number PHHY2012US099002 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 462757) on 01 Nov 2012. This case refers to a 16-year-old female patient. She was vaccinated with MENVEO (batch number: M11047) intramuscularly into her left arm on 17 Aug 2012. On an unspecified date after vaccination she experienced local reaction below the injection site in left upper arm which included of redness, blanching, macular area and mild warmth. She experienced low grade fever the day after vaccination and mild flu like symptoms of headache and dizziness. She had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 21 Aug 2012.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site reaction, Injection site warmth, Pallor, Pyrexia
Clinical narrative: Case number PHHY2012US099002 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 462757) on 01 Nov 2012. This case refers to a 16-year-old female patient. She was vaccinated with MENVEO (batch number: M11047) intramuscularly into her left arm on 17 Aug 2012. On an unspecified date after vaccination she experienced local reaction below the injection site in left upper arm which included of redness, blanching, macular area and mild warmth. She experienced low grade fever the day after vaccination and mild flu like symptoms of headache and dizziness. She had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 21 Aug 2012.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Case number PHHY2012US099014 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 462759) on 01 Nov 2012: This report refers to a 20-year-old female patient. She was vaccinated with MENVEO (batch number: A11064) intramuscularly on 20 Aug 2012. On 21 Aug 2012, 12 hours after the administration of MENVEO, the patient experienced itching, rash and hives. The outcome of events was reported as condition unchanged as of 21 Aug 2012.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US099030 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462880) on 01 Nov 2012. This report refers to a 16-year-old male patient. The patient's medical history included attention deficit disorder and allergy to shellfish. Concomitant medications included melatonin and CONCERTA. He was vaccinated with FLUVIRIN (batch number: 11051) intramuscularly in left arm on 20 Aug 2012. On 21 Aug 2012, after the vaccination, the patient experienced upper (L) arm deltoid muscle redness, swelling and warmth (baseball size). The area was also slightly tender to touch. No drainage. The patient was treated with BENADRYL and cold compresses. The outcome of events was reported as condition unchanged as of 22 Aug 2012.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, VARCEL
Symptoms: Rash
Clinical narrative: Case number PHHY2012US099031 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462922) on 01 Nov 2012. This report refers to a 14-year-old female patient. The patient's medical history included seasonal allergies. She was vaccinated with MENVEO (batch number: M11032) intramuscularly in right leg, GARDASIL (batch number: 0324AE) intramuscularly in left leg and VARIVAX (batch number: 0435AE) subcutaneously in right leg on 22 Aug 2012. On 22 Aug 2012, after the vaccination, the patient experienced light rash on chest and abdomen. The rash resolved a few minutes after use of 2 teaspoons of BENADRYL. The outcome of events was reported as recovered as of 22 Aug 2012.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2012US099041, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 462991) web site on 01 Nov 2012. This report refers to 11 year old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: not reported), and ADACEL (batch number: C3935AA, other manufacturer), into right arm on 21 Aug 2012 and GARDASIL (other manufacturer, batch number: not reported) into right arm on an unspecified date. On an unspecified date the patient complained redness and swelling on right deltoid. The swelling was 100 mm x 8 mm on right. Patient denied of shortness of breath (SOB). The patient was evaluated by doctor and reported that, she went back home with no acute distress. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality assessment of the events were not reported.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Body temperature increased, Dizziness, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Case number PHHY2012US099061, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 463246) web site on 01 Nov 2012. This report refers to 11 year old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A11082), intramuscularly on 23 Aug 2012. On 24 Aug 2012, 18 hours after vaccination, she experienced headache, Temperature of 100.8, dizziness, fatigue, and sweats. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality assessment of the events were not reported.
Age: 40.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: Pruritus, Rash, Skin warm, Swelling
Clinical narrative: Case number PHHY2012US099062 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 463293) on 01 Nov 2012. This case refers to a 40-year-old female patient. Her preexisting condition included of diabetes. Her concomitant medications included of NOVALOG insulin and VICTOZA. She was vaccinated with MENVEO (batch number: A11082) intramuscularly into her left arm on 22 Aug 2012. On the same day she was also vaccinated with ENGERIX-b (other manufacturer, batch number: AHBVC039AA) intramuscularly into her right arm. On 22 Aug 2012 after vaccination she experienced itching, warmth, swelling and rash. She had an emergency doctor visit due to these events. The final outcome was reported as condition unchanged as of 28 Aug 2012. The seriousness and causality of these events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Case number PHHY2012US099076 is an initial spontaneous report received from Vaccine Adverse Event Reporting System website (VAERS reference number: 463305) on 01 Nov 2012. This case refers to a 11-year-old male patient. He was vaccinated with MENVEO (batch number: M11064) intramuscularly into his left leg on 13 Aug 2012. On the same day he was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B081BC) intramuscularly into his right leg. On 13 Aug 2012 after vaccination he experienced red warm area about 8 cm in left leg which was worse than in the right leg at injection site. He was treated with KEFLEX 500 thrice daily for 10 days, MOTRIN and BENADRYL as necessary. He had recovered completely on an unspecified date.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Tremor
Clinical narrative: Case number PHHY2012US099103 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 463433) on 01 Nov 2012. This report refers to a 11-year-old male patient. He was vaccinated with MENVEO (batch number: M11042) in left arm, GARDASIL (batch number: 1860AA) in right arm and BOOSTRIX (batch number: AC52B085BA) in left arm on 16 Aug 2012. On 17 Aug 2012, after the vaccination, the patient experienced hand tremors that lasted for several seconds (7-10). The outcome of events was reported as complete recovery as of 28 Aug 2012.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site swelling, Peripheral swelling
Clinical narrative: Case number PHHY2012US099089 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 463475) on 01 Nov 2012. This report refers to 11-year-old female patient. The patient was vaccinated with MENVEO (batch number: M11051) intramuscularly in left arm on 15 Aug 2012. On 18 Aug 2012, after the vaccination, the patient experienced swelling of left arm (local swelling). The swelling was also down to elbow. The outcome of events was reported as complete recovery as of 29 Aug 2012.
Age: 17.0
Sex: M
Vaccine: MNQ, PPV
Symptoms: Erythema, Myalgia, Oedema, Pyrexia
Clinical narrative: Case number PHHY2012US099179 is an initial spontaneous report received from vaccine adverse reporting system (VAERS reference number: 463566) on 01 Nov 2012. This report refers to a 17-year-old male patient. The patient's medical history included mitochondrial disorder, asthma and allergic rhinitis. The polymedicated patient was vaccinated with MENVEO (batch number: M10135B) intramuscularly in right arm and PNEUMOVAX (batch number: 1417AA) intramuscularly in right arm on 23 Aug 2012. On 24 Aug 2012, after the vaccination, the patient experienced local erythema, edema, fever of 103.6 degrees and generalized myalgia. The patient was given supportive care, ibuprofen, ice and topical hydrocortisone. The outcome of the events was reported as condition unchanged as of 29 Aug 2012.
Age: 13.0
Sex: M
Vaccine: FLUN3, MNQ
Symptoms: Erythema of eyelid, Eyelid rash, Impetigo
Clinical narrative: Case number PHHY2012US099195, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 463904) web site on 01 NOV 2012. This report refers to 13 year old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: 11051) IM into right arm ad FLUMIST (batch number: unknown) on 22 AUG 2012. The patient experienced rash and redness of left eyelid on 28 AUG 2012 and again on 31 AUG 2012 with severe impetigo both nares, face, ears and foot. The outcome of the events, seriousness and causality assessment was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Case number PHHY2012US099202 is an initial spontaneous report received from vaccine adverse event reporting system (VAERS reference number: 463905) on 01 Nov 2012. This report refers to 11-year-old male patient. The patient was vaccinated with MENVEO (batch number: A11082) intramuscularly in left arm on 30 Aug 2012. On 30 Aug 2012, after the vaccination, the patient experienced redness, swelling and induration at the injection site. The patient had indication in the area of 14 by 5 cm. The patient was treated with MEDROL for the events. The outcome of events was reported as condition unchanged as of 30 Aug 2012.
Age: 23.0
Sex: F
Vaccine: MNQ
Symptoms: Fatigue, Myalgia, Pain, Pain in extremity
Clinical narrative: Case number PHHY2012US099205 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 463910) on 01 Nov 2012. This report refers to 23-year-old female patient. The patient was vaccinated with MENVEO (batch number: M11064) intramuscularly in left arm on 17 Aug 2012. On 17 Aug 2012, on the night of vaccination, the patient's arm was soring. Her total body became sore and her muscles hurt. She had no fever, but felt tired. She was using ADVIL for relief and hot showers. The outcome of events was reported as complete recovery as of 31 Aug 2012.
Age: 4.0
Sex: F
Vaccine: MNQ
Symptoms: Urticaria
Clinical narrative: Case number PHHY2012US099213, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464153) web site on 01 Nov 2012. This report refers to 04 year old female patient. Her medical history included alopecia areata. This poly-medicated patient was vaccinated with MENVEO (batch number: A11078), intramuscularly into left arm on 05 Sep 2012. After the vaccination, she was walking out the door when four marks showed up on her skin. The marks looked a little like insect bites and it was confirmed by the patient that these marks were not there before the shot. The patient came back into the exam room and listened for wheezing and at that time, 4 more hives were broke out. No redness around the inject site or hives were noted, but two hives broke out on her side and then two more on her chest. No more hive broke out and 25 minutes after the shot her lung were clear and no addition of rash. The patient received treatment with 5 mg of CLARITIN at about 10 minutes after the shot. The outcomes of the events were reported as not recovered. Seriousness and causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Case number PHHY2012US099318, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464215) web site on 01 Nov 2012. This report refers to 11 year old male patient. It was reported that the patient was well before the vaccination. He was vaccinated with MENVEO (batch number: A11082), intramuscularly into left leg and BOOSTRIX (other manufacture, batch no: AC51B092EA), intramuscularly into right leg on 22 Aug 2012. On 23 Aug 2012, the patient presented with 6 1/2 x 6 cm area of redness of left thigh, and swelling of thigh- 14 cm circumference on right side and 15.5 cm circumference on left side. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality assessment of the events were not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Case number PHHY2012US099324, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464229) web site on 01 Nov 2012. This report refers to 11 year old male patient. He was vaccinated with MENVEO (batch number: A11064), intramuscularly into right arm on 23 Aug 2012. From an unknown date, the patient experienced redness, swelling and soreness from an unknown date (site not specified). It was reported that, his arm circumference was 4 cm larger than other arm. The outcome of the event was reported as complete recovery on an unknown date. The seriousness and causality assessment of the events were not reported.
Age: 11.0
Sex: F
Vaccine: FLUN3, HEPA, HPV4, MNQ, VARCEL
Symptoms: Erythema, Peripheral swelling, Pruritus, Urticaria
Clinical narrative: Case number PHHY2012US099326, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464283) web site on 01 NOV 2012. This report refers to 11 year of female patient. She was vaccinated with MENVEO (batch number: M11051), intramuscularly into  right arm, FLUMIST (other manufacturer, batch no. AH2109) HAVRIX (other manufacturer, batch no: AHAVB605BA) intramuscularly into left arm, GARDASIL (batch number: 0459AE, other manufacturer) intramuscularly into right arm, BOOSTRIX (other manufacturer, batch no. ACB087CB) intramuscularly into left arm and VARIVAX (other manufacturer, batch no H007083) subcutaneously into left arm on 04 SEP 2012. On 05 SEP 2012, the patient experienced right arm redness, swelling, itching and welting. He received treatment with ibuprofen and Benadryl and was being better. The final outcome of the events were reported as recovered. The seriousness and causality assessment of the events was not reported.
Age: 9.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Case number PHHY2012US099327 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 464329) on 01 Nov 2012. This case refers to a 09-year-old male patient. He was vaccinated with MENVEO vaccine (batch number: A11032) intramuscularly into his left arm on 04 Sep 2012. He had an emergency visit to a doctor on 05 Sep 2012. In the emergency room he was found to have swelling and erythema from shoulder to elbow. He had no fever. He had recovered completely from these events on an unspecified date. The seriousness and causality of these events were not reported.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Case number PHHY2012US088218 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464330) on 01 NOV 2012. This report refers to 11-year-old male patient. The patient's medical history included down's syndrome, hypothyroidism, gastroesophageal reflux disease, obstructed sleep apnea and hearing loss. Concomitant medications included Levothroid and albuterol. The patient was vaccinated with MENVOE (batch number: A11032) intramuscularly in right arm, FLUARIX (batch number: AFLUA690AA) intramuscularly in left arm and BOOSTRIX (batch number: AC52B092EA) intramuscularly in left arm on 04 SEP 2012. On 06 SEP 2012, after the vaccination, the patient experienced swelling and redness to arm 5 inches by 4 inches. The outcome of events was reported as complete recovery as of 07 SEP 2012.
Age: 11.0
Sex: F
Vaccine: HPV2, MNQ, TDAP
Symptoms: Erythema, Pruritus
Clinical narrative: Case number PHHY2012US099330 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464370) on 01 Nov 2012. This report refers to 11-year-old female patient. The patient's medical history included nasal allergies. Concomitant medications included ZYRTEC. The patient was vaccinated with MENVEO (batch number: A10057) intramuscularly in right arm, CERVARIX (batch number: AHPVA113AA) intramuscularly in right arm and BOOSTRIX (batch number: AC52B076B) intramuscularly in right arm on 04 Sep 2012. On 04 Sep 2012, after the vaccination, the patient experienced itching, redness distal to injection site (3-4 cm diameter). The outcome of events was reported as condition unchanged as of 06 Sep 2012.
Age: 61.0
Sex: M
Vaccine: MNQ
Symptoms: Oral mucosal erythema, Pyrexia, Rash, Skin warm
Clinical narrative: Case number PHHY2012US099345 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 464695) on 01 Nov 2012: This report refers to a 61-years-old male patient. He was vaccinated with MENVEO (batch number: unknown) on 04 Sep 2012. Two to three hours after vaccination he developed fever and took ADVIL. He recovered after three to four hours. He felt better for two to three days but later developed oral redness and rash which spread to the shoulder and elbow. It was described as wide, flat and hot to touch. He had visited the emergency room following these events. The final outcome of the reaction was reported as not yet recovered as on 04 Sep 2012. No further information about causality and seriousness was provided.
Age: 10.0
Sex: F
Vaccine: MNQ
Symptoms: Chills, Rash pruritic
Clinical narrative: Case number PHHY2012US098995 is an initial spontaneous report received from vaccine adverse event reporting system website (VAERS reference number: 464785) on 01 Nov 2012. This case refers to a 10-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A12009) intramuscularly into her left arm on 31 Aug 2012. After a few minutes of vaccination, she broke out with a rash around the wrist. She complained it was itchy and had chills. She took BENADRYL and ADVIL. Her symptoms subsided after 1.5 hours. No other information was available.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2012US111010, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (reference number: 465195) web site on 04 Dec 2012. This report refers to 11 year old male patient. Concomitant medication included CLARITIN and albuterol. On 06 Sep 2012, he was vaccinated with MENVEO (batch number: A11073) in right arm and BOOSTRIX (batch number: AC52B073CA) in left arm. On 07 Sep 2012, he developed red, swollen, painful area at injection site. Outcome of the event was recovered. Seriousness and causality assessment was not reported.
Age: 16.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Extra dose administered, Myalgia, Pain, Pyrexia
Clinical narrative: Case number PHHY2012US111011 is an initial report received from the Vaccine Adverse Event Reporting System (VAERS reference number 465202) web site on 04 DEC 2012. This report refers to 16-years-old male patient. His current condition included asthma and hyperhidrosis. Concomitant medications include Robinul and Albuterol. He was vaccinated with  MENVEO (batch number: A11064) and BOOSTRIX (other manufacturer, batch number: AC52B077BA) intramuscularly on to left arm and FLUARIX (other manufacturer, batch number: AFLUA690BA) intramuscularly on to right arm on 23 AUG 2012. On an unknown date he had fever, muscle ache and soreness. The reporter stated that patient received second dose of BOOSTRIX inadvertently. The event outcome was reported as recovered on an unspecified date.
Age: 46.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Induration, Musculoskeletal disorder, Pain, Pyrexia
Clinical narrative: Case number PHHY2012US111081 is an initial spontaneous report from Vaccine Adverse Event Reporting System (VAERS reference number 465416) received on 04 Dec 2012. This report refers to a 46-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number M11042) intramuscularly on her right arm and BOOSTRIX (other manufacturer, batch number AC52B079CA) intramuscularly on her left arm on 11 Sep 2012. On 12 Sep 2012, she had an induration of approximately 3 cm at vaccination site on left arm with redness, heat and pain in an area approximately 10 x 12 cm. She had fever of 101. The pain interfered with her sleep and use of arm. She also had small induration in her right arm with no redness or swelling. She went to emergency room and visited a doctor on 17 Sep 2012 who prescribed her a cream and an antibiotic (unspecified). The outcome of the events was reported as not recovered as of 18 Sep 2012. The seriousness and causality assessment of the events was not reported.
Age: 46.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Skin warm, Sleep disorder, Vaccination site induration
Clinical narrative: Case number PHHY2012US111081 is an initial spontaneous report from Vaccine Adverse Event Reporting System (VAERS reference number 465416) received on 04 Dec 2012. This report refers to a 46-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number M11042) intramuscularly on her right arm and BOOSTRIX (other manufacturer, batch number AC52B079CA) intramuscularly on her left arm on 11 Sep 2012. On 12 Sep 2012, she had an induration of approximately 3 cm at vaccination site on left arm with redness, heat and pain in an area approximately 10 x 12 cm. She had fever of 101. The pain interfered with her sleep and use of arm. She also had small induration in her right arm with no redness or swelling. She went to emergency room and visited a doctor on 17 Sep 2012 who prescribed her a cream and an antibiotic (unspecified). The outcome of the events was reported as not recovered as of 18 Sep 2012. The seriousness and causality assessment of the events was not reported.
Age: 11.0
Sex: F
Vaccine: FLUN3, HPV4, MNQ, TDAP
Symptoms: Erythema, Swelling
Clinical narrative: Case number PHHY2012US111214 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number 465640) on 04 DEC 2012. This report refers to 11-year-old female patient. Her medical history included migraines and asthma. Concomitant medications included MaAir, ibuprofen, asmanex and Imitrex. The patient was vaccinated with MENVEO (batch number: AH2139), GARDASIL (batch number:0131AE) intramuscularly in right arm, ADACEL (batch number: U4106AA) intramuscularly in right arm and FLUMIST (batch number: AH2139) on 18 SEP 2012. On 19 SEP 2012, after the vaccination, the patient developed large swollen area with redness. The outcome of events was reported as conditional unchanged as of 19 SEP 2012.
Age: 11.0
Sex: F
Vaccine: FLU3, MNQ, TDAP, VARCEL
Symptoms: Erythema, Peripheral swelling, Pruritus, Pyrexia, Skin warm
Clinical narrative: Case number PHHY2012US111217 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 465694) web site on 04 DEC 2012. This report refers to an 11-year-old female patient. Her medical history and  concomitant medication were not reported. She was vaccinated with MENVEO (batch number: 11041) along with FLUZONE (other manufacturer, batch number: UH711AB) in to the right arm and with ADACEL (other manufacturer, batch number: U4088BA) along with VARIVAX (other manufacturer, batch number: H00702) into the left arm on 31 AUG 2012. After vaccinations her left arm was red, hot and somewhat swollen on an undetermined date. Her mother thought she might have had a mild fever and treated her with ibuprofen and Benadryl, also applied a hydrocortisone cream for itching. On 07 SEP 2012 she went to her doctor who told them if the reaction did not become better by 11 SEP 2012 they should return for a follow-up visit. Outcome of the event were reported as complete recovery. No further information about seriousness and causality was reported.
Age: 11.0
Sex: M
Vaccine: FLUN3, MNQ
Symptoms: Injection site discomfort, Injection site erythema, Injection site joint movement impairment, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2012US111297 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 465892) website on 04 DEC 2012. This report refers to an 11-year-old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number A11074) intradermal in to the right arm along with FLUMIST (other manufacturer, batch number: AH2108) intranasal on 19 SEP 2012. On 20 SEP 2012 mild redness and swelling without pain was noticed at the injection site in right deltoid, increased redness and swelling with warmth was noticed with complaint of discomfort and tightness in arm when moving shoulder joint on the second day; however there was no fever. He had to visit the Emergency Room (ER) following these events. The final outcome was reported as condition unchanged as on 21 SEP 2012. No further information about seriousness and causality was reported.
Age: 11.0
Sex: M
Vaccine: FLU3, MNQ, TDAP
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: Case number PHHY2012US110832, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 465987) web site on 04 DEC 2012. This report refers to 11 year old male patient. His medical history included allergic rhinitis and eczema. Concomitant medication was not reported. She was vaccinated MENVEO (batch number: M11082) into the left arm, FLUZONE (batch number: UH734AD)) into the left arm and BOOSTRIX (batch number: AC52B3094AA) into the right arm on 19 SEP 2012. On 20 SEP 2012, the patient experienced left arm swollen 9/3 area, red, warm to touch and painful. The outcome of the event was condition unchanged. Seriousness and causality assessment was not reported.
Age: 11.0
Sex: M
Vaccine: FLU3, HPV4, MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Tuberculin test
Clinical narrative: Case number PHHY2012US1107840 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System web site(VAERS reference number: 466012) on 04 DEC 2012. This report refers to an 11-year-old male patient. His concomitant medication included PPD. He was vaccinated with MENVEO (batch number: M11033) along with FLUZONE (other manufacturer, batch number: UH719AD) in to the left arm and with GARDASIL (batch number: 0555AE) in to the right arm on 19-SEP-2012. On 20 SEP 2012 he presented with red and swollen left upper arm which was hot to touch. The final outcome was reported as condition unchanged as on 21 SEP 2012. No further information about seriousness and causality was reported.